Maternal gut microbiome regulates immunity to RSV infection in offspring

Wendy Fonseca1, Carrie-Anne Malinczak1, Kei Fujimura2

  • 1Department of Pathology, University of Michigan, Ann Arbor, MI.

Insights

Maternal Lactobacillus supplementation protects offspring from respiratory syncytial virus (RSV) by altering the gut microbiome and reducing inflammation. This probiotic approach enhances neonatal airway immunity against RSV infection.

Area of Science:

  • Immunology
  • Microbiology
  • Neonatal Health

Background:

  • Early life respiratory syncytial virus (RSV) infection can cause lasting immune changes.
  • Previous studies showed Lactobacillus johnsonii reduced airway inflammation in adult mice post-RSV.

Purpose of the Study:

  • To investigate if maternal Lactobacillus johnsonii supplementation protects offspring from RSV-induced airway immunopathology.
  • To determine the mechanisms behind this protection, including microbiome and metabolic changes.

Main Methods:

  • Mice were supplemented with Lactobacillus johnsonii during pregnancy and lactation.
  • Offspring were infected with RSV, and immune responses, lung pathology, and microbiome composition were analyzed.
  • Cross-fostering experiments were used to distinguish prenatal and postnatal effects.

Main Results:

  • Offspring of supplemented mothers showed reduced airway mucus and Th2 immune responses to RSV.
  • Maternal and offspring gut microbiomes were more consistent with supplementation.
  • Plasma and breastmilk from supplemented mothers, and offspring plasma, had lower inflammatory metabolites.
  • Prenatal Lactobacillus exposure decreased Th2 cytokines and lung inflammation; postnatal exposure reduced mucus production.

Conclusions:

  • Lactobacillus modulation of the maternal microbiome and metabolic reprogramming provides significant airway protection against RSV in neonates.
  • This highlights a potential probiotic strategy for preventing severe RSV outcomes in infants.